Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers

Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers

SARS-CoV-2 infection is known to lead to severe morbidity and mortality in patients with liver cirrhosis. For this reason, vaccination of these patients against COVID-19 is widely recommended. However, data regarding immunogenicity in patients with liver cirrhosis is limited and even less is known a...

Full description

Bibliographic Details
Main Authors: Katharina Willuweit, Alexandra Frey, Moritz Passenberg, Johannes Korth, Nissrin Saka, Olympia E. Anastasiou, Birte Möhlendick, Andreas Schütte, Hartmut Schmidt, Jassin Rashidi-Alavijeh
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
vaccination
liver cirrhosis
end-stage liver disease
Online Access:https://www.mdpi.com/2076-393X/10/3/377

Internet

https://www.mdpi.com/2076-393X/10/3/377

Similar Items